JPMorgan Starts PharMerica (PMC) at Market Outperform
More News related to PMC
- PharMerica Names Geoffrey G. Meyers to Its Board of Directors
- UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
- PharMerica to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- PharMerica to Present at the Credit Suisse 18th Annual Healthcare Conference
- PharMerica to Present at the Oppenheimer 20th Annual Healthcare Conference
More News related to New Coverage
- Macquarie Initiates Coverage on Comverge (COMV) with an Outperform
- Macquarie Initiates Coverage on JA Solar (JASO) with an Outperform
- BMO Capital Initiates Coverage on CONSOL Energy (CNX) with a Market Perform
- Roth Capital Initiates Coverage on QKL Stores (QKLS) with a Buy
- J.P. Morgan Resumes Coverage on Express Scripts (ESRX) with an Overweight
JPMorgan initiates coverage on PharMerica Corp. (NYSE: PMC) with a Market Outperform rating.
PharMerica Corporation operates as an institutional pharmacy services company in the United States.
Related Categories
New CoverageStocks Mentioned
+0.16Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
